Cancer (cont.)Medical Author:
Charles Patrick Davis, MD, PhD
Charles Patrick Davis, MD, PhDDr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications. Medical Editor:
Jerry R. Balentine, DO, FACEP
Jerry R. Balentine, DO, FACEPDr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident. In this Article
How is cancer staging determined?There are a number of different staging methods used for cancers and the specific staging criteria varies among cancer types. According to the NCI, the common elements considered in most staging systems are as follows:
However, there are two main methods that form the basis for the more specific or individual cancer type staging. The TMN staging is used for most solid tumors while the Roman numeral or stage grouping method is used by some clinicians and researchers on almost all cancer types. The following is how the NCI describes the TNM staging system:
TX - Primary tumor cannot be evaluated T0 - No evidence of primary tumor Tis - Carcinoma in situ (CIS; abnormal cells are present but have not spread to neighboring tissue; although not cancer, CIS may become cancer and is sometimes called pre-invasive cancer) T1, T2, T3, T4 - Size and/or extent of the primary tumor
NX - Regional lymph nodes cannot be evaluated N0 - No regional lymph node involvement N1, N2, N3 - Involvement of regional lymph nodes (number of lymph nodes and/or extent of spread)
MX - Distant metastasis cannot be evaluated M0 - No distant metastasis M1 - Distant metastasis is present Consequently, a person's cancer could be listed as T1N2M0, meaning it is a small tumor (T1), but has spread to some regional lymph nodes (N2), and has no detected metastasis (M0). The Roman numeral or stage grouping method is described by the NCI as follows:
As mentioned above, variations of these staging methods exist. For example, some cancer registries use surveillance, epidemiology, and end results program (SEER) termed summary staging. SEER groups cancer cases into five main categories:
Staging of cancer is important; it helps the physician to decide on the most effective therapeutic protocols, provides a basis for estimating the prognosis (outcome) for the patient, and provides a system to communicate the patient's condition to other health professionals that become involved with the patients' care. Patient CommentsViewers share their comments
Cancer - Symptoms
Question: What were the symptoms of your cancer?
Cancer - Describe Your Experience
Question: Please describe your experience with cancer.
Cancer - Diagnosis
Question: What form of cancer do you have? Please share how it was diagnosed.
Cancer - Prevention
Question: With a goal of preventing cancer, describe the exams, tests, and lifestyle changes you have experienced.
|
Get the latest health and medical information delivered direct to your inbox FREE!


